States subpoena J&J information
This article was originally published in The Tan Sheet
Executive Summary
Johnson & Johnson reveals multiple state attorneys general are seeking documents related to the April McNeil Consumer Healthcare recalls of Children's Tylenol and other pediatric liquid OTCs. Company officials said during a recent earnings call that the U.S. Attorney's Office for the Eastern District of Pennsylvania issued a grand jury subpoena related to the McNeil recalls (1"The Tan Sheet" July 26, 2010). The company said Aug. 11 in its fiscal 2010 second-quarter Security Exchange Commission filing that it has received civil investigative demands from other states as well. The firm does not expect the legal proceedings to adversely impact its financial condition
You may also be interested in...
McNeil Recalls Cut J&J's Profits, Draw U.S. Attorney's Subpoena
Investment analysts are confident in Johnson & Johnson's long-term viability even though recalls of OTC drugs and the temporary closure of the facility where the products were made prompted the firm to slash full-year profits estimates and triggered a federal investigation
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.